Global /China /Healthcare /Medical Devices /PTHL

iTonic Holdings Ltd.

PTHL

• NASDAQ: PTHL • Delayed

0.3702USD -7.3%

As of 20 June 2026, iTonic Holdings Ltd. has a market cap of $6.31M USD, ranking #43534 globally and #6432 in China. It ranks #3861 in the Healthcare sector, and #814 in the Medical Devices industry.

Global Rank

43534

Country Rank

6432

Sector Rank

3861

Industry Rank

814

Key Stats

Market Cap

$6.31MUSD

Enterprise Value

$4.14MUSD

Revenue (TTM)

$523.03KUSD

EBITDA (TTM)

-$5.17MUSD

Net Income (TTM)

-$5.1MUSD

PS Ratio

13.2

PB Ratio

1.1

Company Profile

Country (HQ)

China

Sector

Healthcare

Industry

Medical Devices

CEO

Jianfei Zhang open_in_new

Employees

Founded

1998

IPO

05 Sep 2024

Website

ftzy.com.cn open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-7.3%	30%	-0.5%	-25%	-36%	-6.9%	-87%	-76%	-76%

News

PTHL Analyst Forecasts

Markets

Exchange	Ticker	Price	Quotes
NASDAQ MIC: XNAS PRIMARY	PTHL 辉腾控股有限公司 Class A Shares ISIN: KYG713991027 Shares Out.: Shares Outstanding: 9.382M¹ Shares Float: 8.319M² TV: TradingView: NASDAQ: PTHL SA: Stock Analysis: NASDAQ: PTHL YF: Yahoo Finance: PTHL GF: Google Finance: NASDAQ: PTHL NQ: NASDAQ: PTHL BA: Barron's: PTHL MS: Morningstar: XNAS: PTHL	0.3702 USD	TV: TradingView: NASDAQ: PTHL SA: Stock Analysis: NASDAQ: PTHL YF: Yahoo Finance: PTHL GF: Google Finance: NASDAQ: PTHL NQ: NASDAQ: PTHL BA: Barron's: PTHL MS: Morningstar: XNAS: PTHL

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About iTonic Holdings Ltd.

iTonic Holdings Ltd., a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy. Its proprietary treatment planning system is a radioactive particle implantation, a radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. The company offers FTTPS, a treatment planning system for treating various malignant tumors, which could determine the target volume, prescription dose, and dose limitation to protect organs at risks and produce dose distribution plan for brachytherapy for cancer patients. The company was formerly known as Pheton Holdings Ltd and changed its name to iTonic Holdings Ltd. in January 2026. iTonic Holdings Ltd. was founded in 1998 and is headquartered in Beijing, China. iTonic Holdings Ltd. operates as a subsidiary of ZJW (BVI) LTD.

Similar Companies

Industry: Medical Devices (China)

Name	Market Cap (USD) diff.	PE	Country
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. SHE: 300760	$30.14B 203.66B CNY 477K%	26.0	China
Shanghai United Imaging Healthcare Co., Ltd. SSE: 688271	$13.65B 92.23B CNY 216K%	48.5	China
Shenzhen New Industries Biomedical Engineering Co., Ltd. SHE: 300832	$5.63B 38.02B CNY 89K%	23.4	China
Intco Medical Technology Co., Ltd. SHE: 300677	$5.54B 37.43B CNY 88K%	52.7	China
APT Medical Inc. SSE: 688617	$5.05B 34.14B CNY 80K%	39.6	China
Andon Health Co., Ltd. SHE: 002432	$4.57B 30.86B CNY 72K%	13.7	China

Industry: Medical Devices (Global)

Name	Market Cap (USD) diff.	PE	Country
Thermo Fisher Scientific Inc. NYSE: TMO	$173.27B 3M%	25.8	United States
Intuitive Surgical, Inc. NASDAQ: ISRG	$160.73B 3M%	56.7	United States
Abbott Laboratories NYSE: ABT	$159.07B 3M%	25.6	United States
Danaher Corp. NYSE: DHR	$126.55B 2M%	34.7	United States
Stryker Corp. NYSE: SYK	$120.69B 2M%	38.3	United States
Medtronic plc NYSE: MDT	$101.9B 2M%	22.2	Ireland

chevron_leftBack